Faeth Therapeutics Acquired by Sensei Biotherapeutics | Healthcare M&A Deal

Sensei Biotherapeutics has acquired Faeth Therapeutics, a biotech other business in Maryland, for $10,000. Faeth Therapeutics is a healthcare biotech company focused on therapeutic development, supporting Sensei Biotherapeutics acquisitions in the biotech other segment. Sensei Biotherapeutics acquisitions expand healthcare M&A capabilities in MD acquisitions and strengthen its merger acquisition pipeline. The merger acquisition was announced as a merger acquisition under an Agreement and Plan of Merger, with disclosed consideration amounts including $1,500 and $0.0001 alongside $10,000, and the deal structure includes potential cash payments tied to preferred stockholders.